Showing results (131-140 of 485) with videos related to
Sort By:
Pageof 49
Current Eye Research|October 1, 2013
Cytotoxic properties of sunitinib and sorafenib on human corneal epithelial cellsTarek Bayyoud, Johanna Hofmann, Martin Spitzer, et al.Retina (Philadelphia, Pa.)|January 11, 2008
Bevacizumab (avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult micePeter Heiduschka, Sylvie Julien, Sabine Hofmeister, et al.Klinische Monatsblatter Fur Augenheilkunde|July 4, 2012
[Clinical results after Descemet membrane endothelial keratoplasty]E Yoeruek, T Bayyoud, D Röck, et al.Klinische Monatsblatter Fur Augenheilkunde|July 4, 2012
[Precut technique for Descemet's membrane endothelial keratoplasty, preparation and storage in organ culture]T Bayyoud, D Röck, J Hofmann, et al.Klinische Monatsblatter Fur Augenheilkunde|July 4, 2012
[Histological and ultrastructural analysis of the Descemet's membrane after descemetorhexis in DMEK surgery]D Röck, T Bayyoud, J Hofmann, et al.Australian and New Zealand Journal of Ophthalmology|December 8, 1998
Failure of sorivudine therapy in progressive outer retinal necrosis caused by varicella zoster virusG Rosenthal, K U Bartz-Schmidt, P Walter, et al.Pigment Cell Research|November 30, 1999
Ultimate fate of rod outer segments in the retinal pigment epitheliumG Thumann, K U Bartz-Schmidt, N Kociok, et al.Acta Ophthalmologica|December 4, 2016
Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experienceDaniela Süsskind, Carina Dürr, Frank Paulsen, et al.Investigative Ophthalmology & Visual Science|October 27, 2006
Phosphenes electrically evoked with DTL electrodes: a study in patients with retinitis pigmentosa, glaucoma, and homonymous visual field loss and normal subjectsFlorian Gekeler, Andre Messias, Max Ottinger, et al.The British Journal of Ophthalmology|October 25, 2014
Rate and timing of spontaneous resolution in a vitreomacular traction group: should the role of watchful waiting be re-evaluated as an alternative to ocriplasmin therapy?Spyridon Dimopoulos, Karl-Ulrich Bartz-Schmidt, Faik Gelisken, et al.Pageof 49